ACWY Vax - powder and solvent for solution for injection, multidoseMeningococcal polysaccharide groups A, C, Y and W135 vaccine Malta - English - Medicines Authority

acwy vax - powder and solvent for solution for injection, multidosemeningococcal polysaccharide groups a, c, y and w135 vaccine

smithkline beecham limited 980, great west road, brentford middlesex tw8 9gs, united kingdom - neisseria meningitidis, polysaccharide group, meningococcal polysaccharide, group w - powder and solvent for solution for injection - neisseria meningitidis polysaccharide group c 50 µg meningococcal polysaccharide group w-135 50 µg - vaccines

ACWY Vax - powder and solvent for solution for injection Meningococcal polysaccharide groups A, C, Y and W135 vaccine Malta - English - Medicines Authority

acwy vax - powder and solvent for solution for injection meningococcal polysaccharide groups a, c, y and w135 vaccine

smithkline beecham limited 980, great west road, brentford middlesex tw8 9gs, united kingdom - neisseria meningitidis, polysaccharide group, meningococcal polysaccharide, group w - powder and solvent for solution for injection - neisseria meningitidis polysaccharide group c 50 µg meningococcal polysaccharide group w-135 50 µg - vaccines

NIMENRIX Meningococcal (Groups A, C, W-135, Y) Polysaccharide Tetanus Toxoid Conjugate Vaccine, injection vial and diluent syringe Australia - English - Department of Health (Therapeutic Goods Administration)

nimenrix meningococcal (groups a, c, w-135, y) polysaccharide tetanus toxoid conjugate vaccine, injection vial and diluent syringe

pfizer australia pty ltd - meningococcal polysaccharide group c, quantity: 5 microgram; meningococcal polysaccharide group y, quantity: 5 microgram; meningococcal polysaccharide group w135, quantity: 5 microgram; meningococcal polysaccharide group a, quantity: 5 microgram; tetanus toxoid, quantity: 44 microgram - injection, powder for - excipient ingredients: sucrose; trometamol hydrochloride - nimenrix is indicated for active immunisation of individuals from 6 weeks of age against invasive meningococcal diseases caused by neisseria meningitidis groups a, c, w-135 and y.

MENINGOCOCCAL POLYSACCHARIDE VACCINE GROUPS A & C KIT Canada - English - Health Canada

meningococcal polysaccharide vaccine groups a & c kit

aventis pasteur sa - meningococcal polysaccharide antigen group a; meningococcal polysaccharide antigen group c - kit - 500mcg; 500mcg - meningococcal polysaccharide antigen group a 500mcg; meningococcal polysaccharide antigen group c 500mcg - vaccines

MENOMUNE VACCINE Singapore - English - HSA (Health Sciences Authority)

menomune vaccine

sanofi-aventis singapore pte. ltd. - meningococcal polysaccharide vaccine groups a, c, y, w-135 - injection, powder, for solution - 50 mcg/ps/0.5 ml - meningococcal polysaccharide vaccine groups a, c, y, w-135 50 mcg/ps/0.5 ml

ACWY Vax - powder and solvent for solution for injection Meningococcal polysaccharide groupsA, C, Y and W135 vaccine Malta - English - Medicines Authority

acwy vax - powder and solvent for solution for injection meningococcal polysaccharide groupsa, c, y and w135 vaccine

smithkline beecham limited 980, great west road, brentford middlesex tw8 9gs, united kingdom - neisseria meningitidis, polysaccharide group, meningococcal polysaccharide, group w - powder and solvent for solution for injection - neisseria meningitidis polysaccharide group c 50 µg meningococcal polysaccharide group w-135 50 µg - vaccines

MenQuadfi meningococcal (Groups A,C,Y,W) polysaccharide tetanus toxoid conjugate vaccine, solution for injection, vial Australia - English - Department of Health (Therapeutic Goods Administration)

menquadfi meningococcal (groups a,c,y,w) polysaccharide tetanus toxoid conjugate vaccine, solution for injection, vial

sanofi-aventis australia pty ltd - meningococcal polysaccharide group w135, quantity: 10 microgram; meningococcal polysaccharide group c, quantity: 10 microgram; meningococcal polysaccharide group a, quantity: 10 microgram; meningococcal polysaccharide group y, quantity: 10 microgram - injection, solution - excipient ingredients: sodium acetate; tetanus toxoid; sodium chloride; water for injections - menquadfi is indicated for active immunisation for the prevention of invasive meningococcal disease caused by neisseria meningitidis serogroups a, c, w and y.,the use of menquadfi should be in accordance with official recommendations.

NIMENRIX meningococcal (Groups A, C, W-135, Y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent ampoul Australia - English - Department of Health (Therapeutic Goods Administration)

nimenrix meningococcal (groups a, c, w-135, y) polysaccharide tetanus toxoid conjugate vaccine injection vial and diluent ampoul

pfizer australia pty ltd - meningococcal polysaccharide group a,meningococcal polysaccharide group c,meningococcal polysaccharide group w135,meningococcal polysaccharide group y,tetanus toxoid -

MENACTRA Australia - English - Department of Health (Therapeutic Goods Administration)

menactra

sanofi-aventis australia pty ltd - diphtheria toxoid, quantity: 48 microgram; meningococcal polysaccharide group y, quantity: 4 microgram; meningococcal polysaccharide group w135, quantity: 4 microgram; meningococcal polysaccharide group c, quantity: 4 microgram; meningococcal polysaccharide group a, quantity: 4 microgram - injection, solution - excipient ingredients: monobasic sodium phosphate; sodium chloride; dibasic sodium phosphate - menactra is indicated for active immunisation of individuals 9 months through 55 years of age for the prevention of invasive meningococcal disease caused by n meningitidis serogroups a, c, y and w-135.,menactra is not indicated for the prevention of meningitis caused by other microorganisms or for the prevention of invasive meningococcal disease caused by n meningitidis serogroup b.,menactra is not indicated for treatment of meningococcal infections.,menactra is not indicated for immunisation against diphtheria.

Menjugate 10 micrograms suspension for injection Meningococcal group C conjugate vaccine Ireland - English - HPRA (Health Products Regulatory Authority)

menjugate 10 micrograms suspension for injection meningococcal group c conjugate vaccine

gsk vaccines s.r.l. - meningococcal group c oligosaccharide; corynebacterium diphtheriae crm197 protein - suspension for injection in pre-filled syringe - 10 - meningococcal vaccines; other meningococcal polyvalent purified polysaccharides antigen - meningococcal vaccines - active immunisation of children from 2 months of age, adolescents and adults, for the prevention of invasive disease caused by neisseria meningitidis group c.